Neurocrine Biosciences
NBIX
#1526
Rank
HK$89.94 B
Marketcap
HK$902.15
Share price
1.62%
Change (1 day)
-13.04%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): HK$3.99 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are HK$2.35 Billion. , an increase over its 2023 earnings that were of HK$2.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 HK$3.98 B64.57%
2023 HK$2.42 B41.13%
2022 HK$1.71 B73.74%
2021 HK$0.98 B-8.82%
2020 HK$1.08 B77.78%
2019 HK$0.60 B49.83%
2018 HK$0.40 B-142.57%
2017 -HK$0.96 Billion-14.73%
2016 -HK$1.13 Billion53.15%
2015 -HK$0.74 Billion46.25%
2014 -HK$0.51 Billion29.66%
2013 -HK$0.39 Billion-3530.8%
2012 HK$11.25 M-95.73%
2011 HK$0.26 B
2009 -HK$0.38 Billion-45.38%
2008 -HK$0.68 Billion-58.87%
2007 -HK$1.65 Billion87.3%
2006 -HK$0.89 Billion351.97%
2005 -HK$0.2 Billion-52.09%
2004 -HK$0.41 Billion-10.98%
2003 -HK$0.46 Billion
2001 -HK$0.35 Billion
1999 -HK$0.16 Billion108.32%
1998 -HK$73.82 Million
1996 HK$22.53 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$0.14 B-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$12.09 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$0.26 Billion-106.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$78.86 B 1,877.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$55.91 B 1,302.10%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$53.94 B 1,252.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$58.3 Million-101.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.33 Billion-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA